Viewing SEC Facts Units
Company Name:
Regulus Therapeutics Inc.
CIK:
1505512
Start Filing Date:
2022-01-01
End Filing Date:
2022-12-31
ACCN:
0001628280-23-009061
Value:
$ 100,000
Value Error:
$ None
Created By:
Date Filed:
2023-03-23
FY:
2022
Fiscal Period:
FY
Frame:
CY2021Q4I
Type:
us-gaap
Form:
10-K
Units:
USD